Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $44.35, but opened at $45.92. Ionis Pharmaceuticals shares last traded at $44.95, with a volume of 147,330 shares. The company reported ($0.06) earnings […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday. IONS has been the subject of a number of other reports. Needham & Company LLC reaffirmed a “buy” rating and set a […]
Rafferty Asset Management LLC increased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 5.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 215,971 shares of the company’s stock after acquiring an additional 11,583 shares during […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares traded down 4.5% during mid-day trading on Thursday . The stock traded as low as $46.84 and last traded at $46.85. 1,400,503 shares were traded during trading, an increase of 23% from the average session volume of 1,139,582 shares. The stock had previously closed at $49.07. […]
Swiss National Bank raised its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 1.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 283,100 shares of the company’s stock after purchasing an additional 3,000 […]